Proteomic Analysis of Cerebrospinal Fluid from Severe COVID‐19 Patients Reveals Prognostic Biomarkers Associated with Disease Outcome
PROTEOMICS – Clinical Applications · 2026-03 · 20 (2)
DOI: 10.1002/prca.70042 ↗At a glance
Journal article in PROTEOMICS – Clinical Applications, published online on 2026-03-14. Written by Harry Alexopoulos and 9 co-authors. Institution: Department of Cell Biology and Biophysics, Faculty of Biology, National and Kapodistrian University of Athens, Athens, Greece. Major MEDLINE topics: COVID-19, Proteomics, Proteome. 26 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Purpose
Coronavirus disease 2019 (COVID‐19) has highlighted significant neurological complications in severe cases. Cerebrospinal fluid (CSF) proteomics could reveal biomarkers related to clinical outcome among critically ill patients. Experimental Design We performed high‐resolution proteomic analyses of CSF samples from 29 intensive care unit (ICU) patients with severe COVID‐19 and 19 controls. Differentially expressed proteins and associated pathways were identified through bioinformatic and statistical analyses.
Results
Proteomic analysis identified 488 significantly altered proteins between COVID‐19 patients and controls. Proteins linked to coagulation, inflammation, and blood‐brain barrier dysfunction (e.g., SERPINC1, KNG1, PLG) were elevated in patients who survived ICU admission. Conversely, proteins associated with metabolic disruption, cellular stress, and neuroinflammation (e.g., FABP3, PDIA4) were upregulated in non‐survivors. Pathway enrichment analyses confirmed involvement of immune activation, inflammatory responses, and coagulation cascades. Conclusions and clinical relevance CSF proteomics in severe COVID‐19 patients reveals potential biomarkers predictive of patient outcomes. These findings support the involvement of systemic inflammation and blood‐brain barrier disruption in COVID‐19 pathophysiology, suggesting novel targets for personalized intervention strategies.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Cell Biology and Biophysics, Faculty of Biology, National and Kapodistrian University of Athens, Athens, Greece.
- Institute For Bioinnovation, BSRC "A. Fleming", Vari, Attica, Greece.
- 1st Department of Intensive Care, Evangelismos Hospital, Faculty of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
- Department of Neurology, General and Oncological Hospital of Kifisia, Athens, Greece.
- Department of Pathophysiology, Faculty of Medicine, National and Kapodistrian University of Athens.
- Center For Clinical, Experimental Surgery & Translational Research, Biomedical Research Foundation, Academy of Athens, Athens, Greece.
ORCID profiles: Harry Alexopoulos, Ioannis Trougakos
Cite
APA
Alexopoulos, H., Samiotaki, M., Gkogkou, E., Mavromati, S., Bitzogli, K., Panagiotou, G., Tzioufas, A., Magira, E., Kotanidou, Α., & Trougakos, I. (2026). Proteomic Analysis of Cerebrospinal Fluid from Severe COVID‐19 Patients Reveals Prognostic Biomarkers Associated with Disease Outcome. PROTEOMICS – Clinical Applications, 20(2). https://doi.org/10.1002/prca.70042
Vancouver
Alexopoulos H, Samiotaki M, Gkogkou E, Mavromati S, Bitzogli K, Panagiotou G, et al. Proteomic Analysis of Cerebrospinal Fluid from Severe COVID‐19 Patients Reveals Prognostic Biomarkers Associated with Disease Outcome. PROTEOMICS – Clinical Applications. 2026;20(2). doi:10.1002/prca.70042
BibTeX
@article{Alexopoulos2026,
author = {Alexopoulos, Harry and Samiotaki, Martina and Gkogkou, Eirini and Mavromati, Sofia and Bitzogli, Kleopatra and Panagiotou, Georgios and Tzioufas, Athanasios and Magira, Eleni and Kotanidou, Αnastasia and Trougakos, Ioannis},
title = {Proteomic Analysis of Cerebrospinal Fluid from Severe COVID‐19 Patients Reveals Prognostic Biomarkers Associated with Disease Outcome},
journal = {PROTEOMICS – Clinical Applications},
year = {2026},
volume = {20},
number = {2},
doi = {10.1002/prca.70042}
}
EUVIMED